A Clinical Trial to Evaluate the Efficacy and Safety of Testosterone Gel in Adult Hypogonadal Males
Public ClinicalTrials.gov record NCT02149264. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Open-Label, Non-Randomized, Clinical Trial to Evaluate the Efficacy and Safety of FE 999303 (Testosterone Gel) in Adult Hypogonadal Males
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a phase 3, open-label, non-randomized, clinical trial to evaluate the efficacy and safety of FE 999303 (Testosterone gel) in adult hypogonadal males.
Study identification
- NCT ID
- NCT02149264
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 160 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 2014 (Type not available)
- Primary completion
- May 2015 (Actual)
- Completion
- Jun 2015 (Actual)
- Last update posted
- Oct 26, 2017
2014 – 2015
United States locations
- U.S. sites
- 22
- U.S. states
- 16
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Investigational site | Anniston | Alabama | — | — |
| Investigational site | Huntsville | Alabama | — | — |
| Investigational site | Newport Beach | California | — | — |
| Investigational site | Denver | Colorado | — | — |
| Investigational site | New Haven | Connecticut | — | — |
| Investigational site | Aventura | Florida | — | — |
| Investigational site | Clearwater | Florida | — | — |
| Investigational site | Mishawaka | Indiana | — | — |
| Investigational site | Watertown | Massachusetts | — | — |
| Investigational site | Troy | Michigan | — | — |
| Investigational site | Edison | New Jersey | — | — |
| Investigational site | Lawrence | New Jersey | — | — |
| Investigational site | Garden City | New York | — | — |
| Investigational site | New York | New York | — | — |
| Investigational site | Poughkeepsie | New York | — | — |
| Investigational site | Purchase | New York | — | — |
| Investigational site | Bala-Cynwyd | Pennsylvania | — | — |
| Investigational site | Warwick | Rhode Island | — | — |
| Investigational site | Mt. Pleasant | South Carolina | — | — |
| Investigational site | Nashville | Tennessee | — | — |
| Investigational site | Webster | Texas | — | — |
| Investigational site | Norfolk | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02149264, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 26, 2017 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02149264 live on ClinicalTrials.gov.